Citomegalovirus: monitoraggio dell’infezione e della terapia nei pazienti trapiantati di rene


Submitted: 25 February 2014
Accepted: 25 February 2014
Published: 31 December 2003
Abstract Views: 1391
PDF: 1604
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

CMV infection is a major cause of disease following renal transplantation. Clinical diagnosis is difficult because the virus usually produces only few, if any, symptoms. Consequently rapid and sensitive diagnostic methods are needed, since clinically effective antiviral therapy is available. Qualitative-quantitative detection of CMV-DNA in leukocytes and in plasma and pp65-antigenaemia are the methods which allow to evidence viral replication activity. In this study we report the our experience about follow-up of 70 kidney transplant recipients. Results indicate that while active CMV infection occured in 25 patients (37,5%), only 11 patients (15,7%) showed antigenaemia and DNAemia values predictive of CMV disease. In this study we also evaluated the efficacy of pre-emptive therapy.

Liritano, N., Lepore, M. G., De Grazia, R., De Fazio, E., Masciari, R., Merando, G., Mantelli, I., Lombardi, L., Scerbo, P., Cosco, L., Ferraro, T., Filia, C., & Vasapollo, I. (2003). Citomegalovirus: monitoraggio dell’infezione e della terapia nei pazienti trapiantati di rene. Microbiologia Medica, 18(4). https://doi.org/10.4081/mm.2003.3031

Downloads

Download data is not yet available.

Citations


Similar Articles

You may also start an advanced similarity search for this article.